Table 1.
Treatment group | rhBMP-2 (μg/mL) | 6 weeks | 12 weeks |
---|---|---|---|
Empty |
0 |
6 |
6 |
ABPs |
0 |
6 |
6 |
BC |
0 |
9 |
10 |
BC+BMP-L |
105 |
9 |
10 |
BC+BMP-H | 420 | 9 | 8 |
rhBMP-2, recombinant human bone morphogenetic protein-2; ABPs, allograft bone particles; BC, biocomposite.